Research Radar archive
What the system was watching on June 16, 2026
Frozen snapshot — captured at . This page does not refresh. Live view: today's Radar.
AI stock ideas
AI stock ideas
Short-term ideas with entry date, tracking window, and public outcome.
DatedTrackedOutcome visibleResearch only
| Ticker | Catalyst | Window | Status | Link |
|---|---|---|---|---|
AMAT Applied Materials, Inc. Technology | Strong AI-capex momentum: stock up about 40% over 21 trading days, Q2 revenue was $7.91B with EPS of $2.86, and Q3 guidance was strong at $8.95B revenue and $3.36 EPS. Management cited strengthening demand and expected 2026 semiconductor equipment growth above 30%. | Jun 16–23 | Active (as of archive) | Open |
FTNT Fortinet, Inc. Technology | Cybersecurity momentum with fresh operating support: Q1 2026 revenue rose 20% YoY, billings rose 31%, and Fortinet raised 2026 revenue guidance. Product catalysts include new FortiGate G series, NVIDIA-related AI security acceleration, and a new cloud-delivered SOC platform, while the stock is up about 15% over 21 trading days. | Jun 16–23 | Active (as of archive) | Open |
INOD Innodata Inc. Technology | AI services catalyst with improving fundamentals: Q1 2026 revenue rose 54% YoY, adjusted EBITDA beat consensus, gross margin expanded to 47%, and full-year 2026 revenue growth guidance was raised to 40%+. New Big Tech engagements are expected to generate about $51M of 2026 revenue, with the stock up about 16.7% over 21 trading days. | Jun 16–23 | Active (as of archive) | Open |
LQDA Liquidia Corporation Healthcare | Constructive biotech momentum with a near-term index catalyst: Q1 2026 net product sales were about $130M, the company posted a third consecutive profitable quarter, and S&P SmallCap 600 inclusion is effective 2026-06-22. Shares are up about 20% over 21 trading days and remain above short-term trend. | Jun 16–23 | Active (as of archive) | Open |
ELAN Elanco Animal Health Incorporated Healthcare | Animal-health name with multiple fresh catalysts: Q1 2026 revenue rose 15% YoY, management raised full-year revenue and adjusted EPS guidance, and recent launches or approvals include Advantage Collar, Befrena, and USDA approval of TruCan Ultra Lyme-L4. The stock is up about 22% over 21 trading days. | Jun 16–23 | Active (as of archive) | Open |
PANW Palo Alto Networks, Inc. Technology | Cybersecurity catalyst from earnings and guidance: fiscal Q3 was described as a double beat with raised guidance, next-gen security ARR reached $8.1B and grew 60%, and product activity includes Koi completion, Portkey acquisition plans, Idira launch, and expanded NWN partnership. Shares are up about 13% over 21 trading days. | Jun 16–23 | Active (as of archive) | Open |
MRVL Marvell Technology, Inc. Technology | AI/data-center semiconductor momentum: recent updates included Q1 revenue above guidance, new AI/data-center product announcements, an acquisition, and a CFO appointment. Transcript data showed Q2 revenue up 58% YoY and data-center revenue up 69% YoY, with Q3 revenue and EPS guided higher. | Jun 16–23 | Active (as of archive) | Open |
STM STMicroelectronics N.V. Technology | Strong AI/data-center catalyst: STM raised its 2026 data-center revenue target to about $1B from nicely above $500M, supported by NVIDIA-linked 800VDC power conversion, silicon photonics progress, AWS-related work, and AI-enabled industrial sensors. Stock momentum is strong, up about 24% over 21 trading days. | Jun 16–23 | Active (as of archive) | Open |
HEI HEICO Corporation Industrials | Aerospace and defense momentum backed by record results: fiscal Q2 2026 net income rose 49%, sales rose 25%, organic growth exceeded 18%, and management cited strong demand across commercial aviation, defense, and space. The stock is up about 15.4% over 21 trading days. | Jun 16–23 | Active (as of archive) | Open |
LLY Eli Lilly and Company Healthcare | High-quality healthcare momentum with major earnings catalysts: Q1 2026 revenue rose 56% to $19.8B, full-year guidance was raised to $82B-$85B, and Mounjaro revenue grew 125% to $8.66B. Positive Phase 3 retatrutide results add pipeline support, with the stock up about 12% over 21 trading days. | Jun 16–23 | Active (as of archive) | Open |
Trust layer
Outcome log
Closed ideas with realised P/L. Winners and losers stay visible.
| Ticker | Window | Outcome | Closed | Link |
|---|---|---|---|---|
LLY Eli Lilly and Company Healthcare | Jun 8–15 | -1.7% | 2026-06-15 | Open |
FTNT Fortinet, Inc. Technology | Jun 8–15 | +4.5% | 2026-06-15 | Open |
INOD Innodata Inc. Technology | Jun 8–15 | -3.0% | 2026-06-15 | Open |
LQDA Liquidia Corporation Healthcare | Jun 8–15 | +12.4% | 2026-06-15 | Open |
TJX The TJX Companies, Inc. Consumer Cyclical | Jun 8–15 | +4.7% | 2026-06-15 | Open |
TNDM Tandem Diabetes Care, Inc. Healthcare | Jun 8–15 | -9.3% | 2026-06-15 | Open |
CORT Corcept Therapeutics Incorporated Healthcare | Jun 8–15 | +13.3% | 2026-06-15 | Open |
ELAN Elanco Animal Health Incorporated Healthcare | Jun 8–15 | +2.6% | 2026-06-15 | Open |
PANW Palo Alto Networks, Inc. Technology | Jun 8–15 | +6.9% | 2026-06-15 | Open |
WLDN Willdan Group, Inc. Industrials | Jun 8–15 | -3.0% | 2026-06-15 | Open |
Weekly rating moves
Rating moves
Upgrades and downgrades captured for the week.
Snapshot — week of 2026-06-16
- WDC8.2Western Digital Corporation · Technology
- TEL8.1TE Connectivity Ltd. · Technology
- PTRN8.1Pattern Group Inc. Series A Common Stock · Technology
- INOD8.0Innodata Inc. · Technology
- PH8.0Parker-Hannifin Corporation · Industrials
- CRDO8.0Credo Technology Group Holding Ltd · Technology
- HEI8.0HEICO Corporation · Industrials
- DECK8.0Deckers Outdoor Corporation · Consumer Cyclical
- ANET8.0Arista Networks, Inc. · Technology
- LLY8.0Eli Lilly and Company · Healthcare
Quant Lab
Quant strategy tests
One concrete backtest at a time — strategy, universe, period, metric, limitation.
Quant Lab
Latest quant strategy test
Regime-Adaptive Relative Momentum on Top 100 Most Traded U.S. Stocks
REGIME_ADAPTIVE_RELATIVE_MOMENTUMregime-adaptiverelative-momentumtop-100liquid-us-stocks2020-01-01..2025-10-08
- Sharpe
- 1.08
- Total return
- +46.4%
- Max drawdown
- -13.2%
- Volatility
- +7.5%
Regime-Adaptive Relative Momentum on Top 100 Most Traded U.S. Stocks — strategy card Spec ID: spec-regime-adaptive-relative-momentum-top100-us-stocks-1779642517 · Generated: 2026-05-24 17:34 UTC One-line description…
Latest run — May 24, 2026. Research artifact, not live performance.
Recently added
- Time-Series Momentum w/ Trend Filter + Volatility/Drawdown Crash Protection (US Stocks)Sharpe 0.73·+65.5%
- Sector Relative Strength Rotation (3/6/12m vs SPY)Sharpe 0.72·+55.7%
- Macro Regime Sector Rotation (Top 500 Most Traded US Stocks)Sharpe 0.81·+113.0%